Gukasyan N - Search Results

1

Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.

Gukasyan N, Griffiths RR, Yaden DB, Antoine DG 2nd, Nayak SM. Gukasyan N, et al. J Psychopharmacol. 2023 Jul;37(7):707-716. doi: 10.1177/02698811231179910. Epub 2023 Jun 8. J Psychopharmacol. 2023. PMID: 37291890

2

Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.

Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR. Davis AK, et al. Among authors: gukasyan n. J Psychopharmacol. 2021 Apr;35(4):437-446. doi: 10.1177/0269881120967878. Epub 2021 Jan 9. J Psychopharmacol. 2021. PMID: 33427007 Free PMC article.

3

Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy.

Gukasyan N, Nayak SM. Gukasyan N, et al. Transcult Psychiatry. 2022 Oct;59(5):652-664. doi: 10.1177/1363461520983684. Epub 2021 Jan 26. Transcult Psychiatry. 2022. PMID: 33499762

4

Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.

Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S, Gukasyan N, Mathur BN, Barrett FS. Yaden DB, et al. Among authors: gukasyan n. Int J Neuropsychopharmacol. 2021 Aug 20;24(8):615-623. doi: 10.1093/ijnp/pyab026. Int J Neuropsychopharmacol. 2021. PMID: 33987652 Free PMC article. Review.

5

Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.

Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. Nayak SM, et al. Among authors: gukasyan n. Pharmacopsychiatry. 2021 Sep;54(5):240-245. doi: 10.1055/a-1524-2794. Epub 2021 Aug 4. Pharmacopsychiatry. 2021. PMID: 34348413

6

The Potential of Psychedelics for End of Life and Palliative Care.

Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR. Yaden DB, et al. Among authors: gukasyan n. Curr Top Behav Neurosci. 2022;56:169-184. doi: 10.1007/7854_2021_278. Curr Top Behav Neurosci. 2022. PMID: 34958455 Review.

7

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.

Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR. Gukasyan N, et al. J Psychopharmacol. 2022 Feb;36(2):151-158. doi: 10.1177/02698811211073759. J Psychopharmacol. 2022. PMID: 35166158 Free PMC article. Clinical Trial.

8

Psychedelic-Assisted Therapy for People with Eating Disorders.

Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS. Gukasyan N, et al. Curr Psychiatry Rep. 2022 Dec;24(12):767-775. doi: 10.1007/s11920-022-01394-5. Epub 2022 Nov 14. Curr Psychiatry Rep. 2022. PMID: 36374357 Review.

9

Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms.

Nikolaidis A, Lancelotta R, Gukasyan N, Griffiths RR, Barrett FS, Davis AK. Nikolaidis A, et al. Among authors: gukasyan n. J Affect Disord. 2023 Mar 1;324:239-249. doi: 10.1016/j.jad.2022.12.042. Epub 2022 Dec 27. J Affect Disord. 2023. PMID: 36584715 Free PMC article.

10

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.

Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR. Raison CL, et al. Among authors: gukasyan n. JAMA. 2023 Sep 5;330(9):843-853. doi: 10.1001/jama.2023.14530. JAMA. 2023. PMID: 37651119 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page